¸½½üÉÏÃÅ

Here’s what you need to know today in startup and venture news, updated by the ¸½½üÉÏÃÅ News staff throughout the day to keep you in the know.

Subscribe to the ¸½½üÉÏÃÅ Daily

Robinhood seeks valuation of up to $35B in upcoming IPO

Stock and crypto trading platform is seeking a valuation of up to $35 billion for its upcoming public offering, according to a citing its amended IPO prospectus .

The filing sets a price range of $38 to $42 per share for the offering, which would raise up to $2.54 billion for the Menlo Park, California-headquartered company.

The commission-free trading platform said it brought in $959 million in revenue in 2020, up 245 percent year over year. The company also turned a profit in 2020, generating $7 million in net income after incurring $107 million in net losses in 2019.

— Joanna Glasner

Zoom buying Five9 for $14.9B

announced that it is acquiring , a provider of cloud-based contact center software, in an all-stock deal valued at around $14.7 billion.

San Jose-based Zoom said the acquisition is expected to help enhance its presence with enterprise customers and accelerate its growth opportunity by adding the $24 billion contact center market to its focus areas. Founded in 2001, San Ramon, California-based Five9 raised its last known venture funding round in 2013, with total VC funding of around $114 million, per ¸½½üÉÏÃÅ data.

— Joanna Glasner

Health tech

• Frontier Medicines finds $88.5M for precision medicine:  Corp. a South San Francisco-based a precision medicine company, said it has raised an $88.5 million Series B funding. The deal was co-led by Ìý²¹²Ô»å , with equal participation by Deerfield Management Company. Other new investors in the round included , , and Sphera Healthcare alongside existing investors , Droia Ventures and . Frontier Medicine says it seeks “to unlock the proteome to advance breakthroughs against otherwise undruggable disease-causing targets.”  

•Omniscient Neurotechnology raises Series B for brain mapping: , a brain mapping technology company, said it has closed an AUD $40 million (~$29.4 million USD) Series B funding. The funding for the Sydney, Australia-based company was led by family offices and high-net worth individuals, including Executive Chairman and fund manager . Omniscient said its technology could be used by doctors, psychologists, neuroscientists and others in the brain health space to better treat neurological disorders and mental illnesses.

Ed-tech

Go1 raises $200M: Australia-based , a provider of learning tools for enterprises, raised $200 million in a Series D round led by 2, and 1. The latest round reportedly for the company of over $1 billion.

— Joanna Glasner

Illustration: